4 studies found for:    PSEN1
Show Display Options
Rank Status Study
1 Recruiting A Study of Crenezumab Versus Placebo in Preclinical PSEN1 E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease, Including a Placebo-Treated Noncarrier Cohort.
Condition: Alzheimer Disease
Interventions: Drug: crenezumab;   Drug: placebo
2 Recruiting Central and Systemic Inflammation in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
3 Unknown  Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
Conditions: Alzheimer's Disease;   Dementia;   Neurodegenerative Disorders
Intervention: Other: Blood sampling, skin biopsy
4 Active, not recruiting Genetics of Mendelian Forms of Young Onset Alzheimer Disease
Condition: Autosomal Dominant Cases of Alzheimer 's Disease
Intervention:

Indicates status has not been verified in more than two years